Articles published by Carterra

Leerink Partners Report Names Carterra a Core Enabler of the $7B "Lab-in-the-Loop" Antibody Discovery Market

Today 8:00 EDT

From Carterra

Via Business Wire

William Blair Analysts Name Carterra a Winner in Life Science Tools for Enabling AI Drug Discovery at Unprecedented Scale

April 08, 2026

From Carterra

Via Business Wire

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

February 09, 2026

From Carterra

Via GlobeNewswire

Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies

April 24, 2025

From Carterra

Via GlobeNewswire

Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues

January 07, 2025

From Carterra

Via GlobeNewswire

Carterra Expands Best-in-Class Franchise With the Launch of the LSAXT High-Throughput SPR Biosensor at SLAS 2023

February 27, 2023

From Carterra

Via Business Wire

Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year® Mountain West Award Winner

September 07, 2022

From Carterra

Via Business Wire

University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization

June 08, 2022

From Carterra

Via Business Wire

Genovac Acquires the Carterra LSA® Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services

April 20, 2022

From Carterra

Via Business Wire

Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions

December 14, 2021

From Carterra

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.